OraSure Tech

Q2 FY2026 EarningsQ2 FY2026 results significantly beat consensus on the bottom line, with a GAAP EPS of $0.09 vs. expected -$0.27. Revenue was $30.6M, slightly above the $29.1M mean estimate, while gross margin outperformed at 43.5% vs. 42.0% expected. The earnings beat was primarily driven by a $22.6M non-cash gain from a reduction in the fair value of acquisition-related contingent consideration, following the withdrawal of an FDA submission for a key CT/NG product line.